2017 Annual Meeting of the American Association for the Study of Liver Diseases*

October 20-24, 2017; Washington, DC
Review Capsule Summaries, download slides, and read ClinicalThought commentaries on key studies from Washington, DC 2017.
Jordan J. Feld, MD, MPH
Ira M. Jacobson, MD
Philip N. Newsome, PhD, FRCPE
Tram T. Tran, MD

Downloadable Slides

In this downloadable slideset, expert faculty members Stephen A. Harrison, MD, COL (Ret.), FAASLD; Paul Y. Kwo, MD; and Norah Terrault, MD, MPH, FAASLD, summarize key studies from this important annual conference.

Released: November 7, 2017


Studies presented at the 2017 hepatology meeting in Washington, DC, sought to provide answers to questions surrounding mortality and HCC risk in patients with HCV who achieved SVR with DAA therapy. Here’s my take.

Jordan J. Feld, MD, MPH Released: November 14, 2017

At AASLD 2017, exciting new data were presented on both current and investigational therapies for chronic HBV infection.

Tram T. Tran, MD Released: November 30, 2017

Here’s my take on how new data from AASLD 2017 on noninvasive imaging modalities and emerging investigational agents may affect the NAFLD/NASH patient management landscape.

Philip N. Newsome, PhD, FRCPE Released: January 8, 2018

How will data presented at AASLD 2017 on 8-week therapy have an impact on management of patients with HCV infection? Here’s my take.

Ira M. Jacobson, MD Released: January 9, 2018

Downloadable Audio

Listen to downloadable audio from a series of live Webinars by Stephen A. Harrison, MD, COL (Ret.), FAASLD; Paul Y. Kwo, MD; and Norah Terrault, MD, MPH, FAASLD, in which the clinical impact of new data reported at the Washington, DC meeting is discussed.

Released: November 20, 2017

Hepatitis C

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)

Educational grant provided by:
Gilead Sciences
Merck & Co., Inc.

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?